
AmberCRO has been
awarded by the Latvian Governmental Institution (LIAA)
...[more]
AmberCRO has been selected as one of 10
Country Representatives ...[more]
AmberCRO is
planning first Clinical Trials in Belarus
...
[more]
AmberCRO has received appreciation for successful collaboration with the German
companies
...
[more]
AmberCRO had received ISO 9001:2008
...
[more]
|
AmberCRO
conducts all Clinical trial activities under GCP
standards.
AmberCRO
can provide all
clinical trial activities for a Clinical trial.
AmberCRO
can perform Clinical trials Phase I-IV in Baltic States
(Latvia, Lithuania and Estonia) and Multinational Clinical
trials.
AmberCRO has
reliable partners in America, Russia, Ukraine, Hungaria
etc.
-
Selection process. Site and
Investigator selection.
-
Regulatory Consultation.
Preparation and submission of Regulatory documents
(clinical trial application/ Notification).
-
Interaction
with the Investigator. AmberCRO has its own Data Base
with experienced investigators (endocrinology,
cardiology, inflammatory diseases, surgery, neurology,
psychiatry, vascular surgery, gastroenterology,
urology, oncology, dermatology, ophthalmology,
(dentists, pediatricians), etc.
-
Organize Investigator meeting,
qualify and train Investigators
-
ICH/GCP training (see
ICH
GCP for web_ENG and
ICH GCP for web_LAT )
-
Site Management and Monitoring
Based on SOP's and study specific procedures.
-
Site Initiation
-
Monitoring visits
-
100% SDV
-
Adverse Event report
-
Site Closure visits
|
|